Vanguard closes private placement of $375 million 7.750% Senior Notes

NewsGuard 100/100 Score

Vanguard Health Systems, Inc. (NYSE: VHS) ("Vanguard") announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the "Issuers"), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019 (the "New Notes").

The New Notes were issued pursuant to the indenture, dated as of January 26, 2011 (the "Indenture"), governing their existing 7.750% Senior Notes due 2019 (the "Existing Notes"). The New Notes were issued at an offering price of 99.25% plus accrued interest from February 1, 2012. The New Notes will be treated as a single series with the Existing Notes, except that (i) the New Notes are subject to a separate registration rights agreement and (ii) unless and until the New Notes are registered, the New Notes will have a different CUSIP number from that of the Existing Notes and will not be fungible with the Existing Notes.

The Issuers intend to use the net proceeds from the offering of the New Notes for general corporate purposes, which may include, but not be limited to, working capital, capital expenditures, acquisitions, the repayment of any outstanding indebtedness under Vanguard's existing revolving credit facility, and to pay the fees and expenses incurred in connection with the offering.

Source Vanguard Health Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The menopausal symptoms and food consumption in post-menopausal women before and during the COVID-19 pandemic